Vivos Therapeutics, Inc. VVOS
0.08 USD 0.00 (+0.00%)
Regular-session close
0.07 0.00 -1.84%
Pre-market · Nov 19, 8:52 AM ET
Day range unavailable
0.071 52-week range 2.69
- YTD
- -96.26%
- 1 year
- -96.92%
News
seekingalpha.com Vivos Therapeutics, Inc. (VVOS) Q3 2026 Earnings Call Prepared Remarks Transcript Vivos Therapeutics, Inc. ( VVOS ) Q3 2026 Earnings Call November 16, 2026 5:00 PM EST Company Participants Roman Franklin - Chief Financial Officer R. Huntsman - Co-Founder, Chairman of the Board &…benzinga.com Reported Earlier, Vivos Therapeutics Q3 EPS $(0.07) Beats $(0.42) Estimate, Sales $6.414M Beat $5.937M Estimate Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.42) by 83.33 percent. This is a 85.71 percent increase over losses of…
zacks.com Vivos Therapeutics, Inc. (VVOS) Reports Q3 Loss, Beats Revenue Estimates Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.49 per share a year ago.
globenewswire.com Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update Revenue rises 24% quarter over quarter as Third quarter operating loss improves 18% year over year on cost reductions; Company regained compliance with Nasdaq stockholders' equity requirement
benzinga.com Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 3M shares rose 4.4% premarket after expanding its Amazon data-center deal, including a $521.4M stock warrant; other stocks saw sharp moves.benzinga.com Vivos Therapeutics Closes Its Acquisition Of An 11% Fully Diluted Equity Interest In Sod Sciences And A 50% Undivided Co-Ownership Interest In SOD's Pseudohypoxia Early‑Warning Test, The "Primed Cell For Chronic Disease" Test; Vivos Issued To SOD 12,000 Shares Of Newly Created Series C Convertible Preferred Stock With An Aggregate Stated Value Of $12M Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or the "Company") today announced that it has closed its acquisition of an 11% fully diluted equity interest in SOD Sciences, Inc. ("SOD Sciences"
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 17.9% to $0.16 during Monday's after-market session. The market value of their outstanding shares is at $2.8 million. SCWorx (NASDAQ:WORX)…
